Long-term Treatment Benefits With Tiotropium in COPD Patients With and Without Short-term Bronchodilator Responses
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine
Reference30 articles.
1. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease;American Thoracic Society;Am J Respir Crit Care Med,1995
2. Standardization of spirometry: 1994 update;American Thoracic Society;Am J Respir Crit Care Med,1995
3. Guidelines for the evaluation of impairment/disability in patients with asthma;American Thoracic Society/Medical Section of the American Lung Association;Am Rev Respir Dis,1993
4. Use of a long-acting inhaled beta2-adrenergic agonist, salmeterol xinafoate, in patients with chronic obstructive pulmonary disease;Rennard;Am J Respir Crit Care Med,2001
5. Early reversibility to salbutamol does not always predict bronchodilation after salmeterol in stable chronic obstructive pulmonary disease;Cazzola;Respir Med,1998
Cited by 130 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trial;Respiratory Research;2021-10-28
2. Identifying bronchoconstriction from the ratio of diaphragm EMG to tidal volume;Respiratory Physiology & Neurobiology;2021-09
3. Diagnostic performance of lung volumes in assessment of reversibility in chronic obstructive pulmonary disease;The Egyptian Journal of Bronchology;2021-05-01
4. The paradoxical response to short-acting bronchodilator administration in patients with chronic obstructive pulmonary disease;Journal of Thoracic Disease;2021-02
5. Efficacy of Indacaterol/Glycopyrrolate in Patients with COPD by Airway Reversibility at Baseline: A Pooled Analysis of the FLIGHT1 and FLIGHT2 12-Week Studies;COPD: Journal of Chronic Obstructive Pulmonary Disease;2019-03-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3